159 results on '"Michel, G."'
Search Results
2. Incidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years: TBI is what really matters
3. Prevalence and risk factors of iron overload after hematopoietic stem cell transplantation for childhood acute leukemia: a LEA study
4. Metabolic syndrome in adults who received hematopoietic stem cell transplantation for acute childhood leukemia: an LEA study
5. Hematopoietic stem cell transplantation in relapsed ALK+ anaplastic large cell lymphoma in children and adolescents: a study on behalf of the SFCE and SFGM-TC
6. Full but impaired activation of innate immunity effectors and virus-specific T cells during CMV and EBV disease following cord blood transplantation
7. Health status of childhood leukemia survivors who received hematopoietic cell transplantation after BU or TBI: an LEA study
8. OUTCOMES OF UNRELATED CORD BLOOD TRANSPLANTATION FOR PATIENTS WITH INFANT LEUKEMIA: PH-O114
9. UNRELATED DOUBLE CORD BLOOD TRANSPLANTATION IN CHILDREN: A RETROSPECTIVE ANALYSIS ON BEHALF OF EUROCORD AND PDWP-EBMT: PH-O098
10. OUTCOMES OF ALLOGENEIC CORD BLOOD TRANSPLANTATION FOR LEUKODYSTROPHIES; A JOINT STUDY OF EUROCORD AND “INBORN ERRORS WP-EBMT”: PH-O069
11. Impact on long-term OS of conditioning regimen in allogeneic BMT for children with AML in first CR: TBI + CY versus BU + CY: a report from the Société Française de Greffe de Moelle et de Thérapie Cellulaire
12. Impact of HLA mismatch direction on outcomes after umbilical cord blood transplantation for hematological malignant disorders: a retrospective Eurocord-EBMT analysis
13. Reduced-intensity conditioning followed by allogeneic transplantation in pediatric malignancies: a report from the Société Française des Cancers de lʼEnfant and the Société Française de Greffe de Moelle et de Thérapie Cellulaire
14. Clinical evidence implicating gamma-delta T cells in EBV control following cord blood transplantation
15. Allogeneic stem cell transplantation in infants below one and two years old with acute leukaemia: results of a retrospective study in EBMT centres from 2000 to 2010, on behalf of EBMT-PDWP: O341
16. Growth hormone treatment impact on growth rate and final height of patients who received HSCT with TBI or/and cranial irradiation in childhood: a report from the French Leukaemia Long-Term Follow-Up Study (LEA)
17. Haematopoietic stem cell transplantation for β-thalassaemia major: the French experience: P612
18. Growth hormone treatment impact on growth rate and final height of patients who received haematopoietic cell transplantation with TBI or/and CI in childhood: a report from the French Leukaemia Long-Term Follow-Up Study: O181
19. Total nucleated and CD34 cell dose and their impact on engraftment and NRM after single unrelated cord blood transplantation for patients with haematological malignancies: O161
20. Effect of donor-recipient HLA-matching at the HLA-C locus on outcomes after unrelated cord blood transplant for leukaemia: O163
21. Outcomes of unrelated cord blood transplantation in children with acute myeloid leukaemia. A survey on behalf of Eurocord, ALWP and PDWP of EBMT: O167
22. Impact of total nucleated (TNC) and CD34+ cell dose on different outcomes after double unrelated cord blood transplantation in patients with haematological malignancies. An analysis on behalf of the SFGM-TC and Eurocord: O162
23. Incidence and risk factors of chronic graft-versus-host disease after unrelated cord blood transplant. A retrospective study on behalf of EUROCORD and Late-Effect Working Party of EBMT: 135
24. Height growth during adolescence and final height after haematopoietic SCT for childhood acute leukaemia: the impact of a conditioning regimen with BU or TBI
25. Survey of outcomes of unrelated cord blood transplant in patients with severe acquired aplastic anaemia and paroxysmal nocturnal haemoglobinuria. A study by EUROCORD and the Aplastic Anaemia Working party of the EBMT: O298
26. Health status and quality of life in long-term survivors of childhood leukaemia: the impact of haematopoietic stem cell transplantation
27. CD34+ progenitors are reproducibly recovered in thawed umbilical grafts, and positively influence haematopoietic reconstitution after transplantation
28. Hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: experience of the French neutropenia registry
29. Late thyroid toxicity in 153 long-term survivors of allogeneic bone marrow transplantation for acute lymphoblastic leukaemia
30. Unrelated cord blood transplant in adults with haematologic malignancies
31. Survey on treatment strategies in children with 2ND CR acute lymphoblastic leukaemia who underwent stem cell transplantation
32. Haematopoietic stem cell transplantation in childhood: report from the Paediatric Diseases Working Party of the European Bone Marrow Transplantation Group
33. Hematopoietic stem cell transplantation in severe congenital neutropenia: experience of the French SCN register
34. Allogeneic bone marrow transplantation for chronic myeloid leukemia in childhood: a report from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
35. Hematopoietic stem cell transplantation in patients with severe Langerhans cell histiocytosis and hematological dysfunction: Experience of the French Langerhans Cell Study Group
36. Outcome after failure of allogeneic hematopoietic stem cell transplantation in children with acute leukemia: a study by the société Francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)
37. Prevalence and risk factors of iron overload after hematopoietic stem cell transplantation for childhood acute leukemia: a LEA study
38. Erratum: Impact of HLA mismatch direction on outcomes after umbilical cord blood transplantation for hematological malignant disorders: a retrospective Eurocord-EBMT analysis
39. Impact on long-term OS of conditioning regimen in allogeneic BMT for children with AML in first CR: TBI+CY versus BU+CY: a report from the Société Française de Greffe de Moelle et de Thérapie Cellulaire
40. Impact of HLA mismatch direction on outcomes after umbilical cord blood transplantation for hematological malignant disorders: a retrospective Eurocord-EBMT analysis
41. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP)
42. Long-term side-effects in children receiving allogeneic bone marrow transplantation in first complete remission of acute leukaemia
43. Cytogenetics and outcome of allogeneic transplantation in first remission of acute myeloid leukemia: the French pediatric experience
44. Growth hormone treatment impact on growth rate and final height of patients who received HSCT with TBI or/and cranial irradiation in childhood: a report from the French Leukaemia Long-Term Follow-Up Study (LEA)
45. Lung toxoplasmosis after HLA mismatched bone marrow transplantation
46. Height growth during adolescence and final height after haematopoietic SCT for childhood acute leukaemia: the impact of a conditioning regimen with BU or TBI
47. Hematopoietic stem cell transplantation in severe congenital neutropenia: experience of the French SCN register
48. Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM)
49. Immune reconstitution and outcome after unrelated cord blood transplantation: a single paediatric institution experience
50. First report of Epstein-Barr virus lymphoproliferative disease after cord blood transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.